LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Circadian variation in hematotoxicity of the antineoplastic agent “5 Fluorouracil (5 FU)” in female rats and its relevance to chronotherapy

Photo by lee_hisu from unsplash

ABSTRACT 5-Fluorouracil (5-FU) is an antineoplastic drug. Although 5-FU is effective in targeting cancer cells, it also affects healthy cells, which can lead to clear haematological toxicity. The present study… Click to show full abstract

ABSTRACT 5-Fluorouracil (5-FU) is an antineoplastic drug. Although 5-FU is effective in targeting cancer cells, it also affects healthy cells, which can lead to clear haematological toxicity. The present study aimed to determine whether the haematological toxicity of 5-FU varies over a 24-hour period. Female rats were synchronised to a 12/12 light-dark (L/D) cycle. Rats were injected with 300 mg/kg 5-FU at six different circadian stages (1, 5, 9, 13, 17, 21 Zeitgebers (ZT)). The maximum rhythmic alteration was observed when 5-FU was administered at 5-ZT, while the minimum was observed at 21-ZT. These results suggest that the haematological toxicity of 5-FU is maximal when administered in the middle of the light-rest phase, while the haematological tolerance is optimal when 5-FU is administered at the end of the dark phase in rats, which corresponds to the end of the daytime activity phase in human patients. 

Keywords: female rats; circadian variation; antineoplastic agent; haematological toxicity; hematotoxicity antineoplastic; variation hematotoxicity

Journal Title: Biological Rhythm Research
Year Published: 2023

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.